High intensity, low frequency catheter-delivered ultrasound dissolution of occlusive coronary artery thrombi: an in vitro and in vivo study

Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California 90048.

OBJECTIVES. This study assessed the efficacy of a new high intensity, low frequency therapeutic coronary ultrasound catheter for thrombus dissolution in vitro and in vivo in canine coronary arteries. BACKGROUND. Therapeutic ultrasound has been shown to dissolve thrombi in vitro and in peripheral arteries in vivo. There have been no previous studies on in vivo coronary thrombus dissolution by ultrasound. METHODS. In vitro, we exposed 1- to 4-h old human blood clots for 3 min to pulsed-wave ultrasound. Clot dissolution under various conditions was evaluated. In vivo occlusive coronary thrombi were induced in 18 dogs. RESULTS. In vitro irrigation alone (10 ml/min of normal saline solution) and ultrasound alone each contributed to a reduction of clot weight by 47.1 +/- 11.4 mg and 84.6 +/- 25.6 mg, respectively, after 3 min (p < 0.001). Ultrasound plus irrigation resulted in a reduction of clot weight by 216.5 +/- 31.5 mg after 3 min (p < 0.001). The magnitude of clot dissolution was considerably amplified when ultrasound energy was combined with irrigation, probably because of cavitational effects. In vivo, in three dogs mechanical passage of the unactivated probe failed to recanalize the artery, and the arteries remained thrombotically occluded. After passage of the activated ultrasound probe, angiography revealed widely patent coronary arteries in 13 of 15 dogs and partial recanalization with filling defects indicative of residual thrombus in 2 of 15 dogs. Three of 15 coronary arteries were histologically free of residual thrombi. Mural thrombi extending to < or = 10% of the vessel circumference were seen in 10 of 15 dogs. Residual thrombi > or = 50% of the vessel circumference were found in two cases. There was no histologic evidence of ultrasound-mediated vessel damage. CONCLUSIONS. Catheter-delivered therapeutic ultrasound effectively dissolves clots in vitro and in canine coronary arteries in vivo. Thus, therapeutic catheter-delivered ultrasound has the potential to serve as an adjunct or alternative treatment for thrombus-mediated coronary ischemic syndromes or myocardial infarction.

This article has been cited by other articles:

				C. W Francis and V. N Suchkova Ultrasound and thrombolysis Vascular Medicine, August 1, 2001; 6(3): 181 - 187. [Abstract] [PDF]

				R. J. Siegel, S. Atar, M. C. Fishbein, A. V. Brasch, T. M. Peterson, T. Nagai, D. Pal, T. Nishioka, J.-S. Chae, Y. Birnbaum, et al. Noninvasive, Transthoracic, Low-Frequency Ultrasound Augments Thrombolysis in a Canine Model of Acute Myocardial Infarction Circulation, May 2, 2000; 101(17): 2026 - 2029. [Abstract] [Full Text] [PDF]

				V. Suchkova, F. N. Siddiqi, E. L. Carstensen, D. Dalecki, S. Child, and C. W. Francis Enhancement of Fibrinolysis With 40-kHz Ultrasound Circulation, September 8, 1998; 98(10): 1030 - 1035. [Abstract] [Full Text] [PDF]

				Y. Birnbaum, H. Luo, T. Nagai, M. C. Fishbein, T. M. Peterson, S. Li, D. Kricsfeld, T. R. Porter, and R. J. Siegel Noninvasive In Vivo Clot Dissolution Without a Thrombolytic Drug : Recanalization of Thrombosed Iliofemoral Arteries by Transcutaneous Ultrasound Combined With Intravenous Infusion of Microbubbles Circulation, January 20, 1998; 97(2): 130 - 134. [Abstract] [Full Text] [PDF]

				P. G. Yock and P. J. Fitzgerald Catheter-Based Ultrasound Thrombolysis: Shake, Rattle, and Reperfuse Circulation, March 18, 1997; 95(6): 1360 - 1362. [Full Text]

				H. Luo, T. Nishioka, M. C. Fishbein, B. Cercek, J. S. Forrester, C.-J. Kim, H. Berglund, and R. J. Siegel Transcutaneous Ultrasound Augments Lysis of Arterial Thrombi In Vivo Circulation, August 15, 1996; 94(4): 775 - 778. [Abstract] [Full Text]